Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H13F2NO4S |
| Molecular Weight | 353.341 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(=O)(=O)NC1=C(OC2=C(F)C=C(F)C=C2)C=C3C(=O)CCC3=C1
InChI
InChIKey=CXJONBHNIJFARE-UHFFFAOYSA-N
InChI=1S/C16H13F2NO4S/c1-24(21,22)19-13-6-9-2-4-14(20)11(9)8-16(13)23-15-5-3-10(17)7-12(15)18/h3,5-8,19H,2,4H2,1H3
| Molecular Formula | C16H13F2NO4S |
| Molecular Weight | 353.341 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Flosulide, a selective cyclooxygenase-2 (COX-2) inhibitor, was studied for the treatment for inflammatory diseases. It was shown, that selective inhibition of COX-2 could alter renal function and could be useful in the therapy of esophageal cancer. Experiments on rodent have revealed that therapeutic use of flosulide in proteinuria could be a benefit.
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:09:01 GMT 2025
by
admin
on
Mon Mar 31 18:09:01 GMT 2025
|
| Record UNII |
GVR41S4ZHJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1323
Created by
admin on Mon Mar 31 18:09:01 GMT 2025 , Edited by admin on Mon Mar 31 18:09:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
71246
Created by
admin on Mon Mar 31 18:09:01 GMT 2025 , Edited by admin on Mon Mar 31 18:09:01 GMT 2025
|
PRIMARY | |||
|
SUB07655MIG
Created by
admin on Mon Mar 31 18:09:01 GMT 2025 , Edited by admin on Mon Mar 31 18:09:01 GMT 2025
|
PRIMARY | |||
|
80937-31-1
Created by
admin on Mon Mar 31 18:09:01 GMT 2025 , Edited by admin on Mon Mar 31 18:09:01 GMT 2025
|
PRIMARY | |||
|
GVR41S4ZHJ
Created by
admin on Mon Mar 31 18:09:01 GMT 2025 , Edited by admin on Mon Mar 31 18:09:01 GMT 2025
|
PRIMARY | |||
|
DTXSID20230807
Created by
admin on Mon Mar 31 18:09:01 GMT 2025 , Edited by admin on Mon Mar 31 18:09:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL147580
Created by
admin on Mon Mar 31 18:09:01 GMT 2025 , Edited by admin on Mon Mar 31 18:09:01 GMT 2025
|
PRIMARY | |||
|
C059178
Created by
admin on Mon Mar 31 18:09:01 GMT 2025 , Edited by admin on Mon Mar 31 18:09:01 GMT 2025
|
PRIMARY | |||
|
6600
Created by
admin on Mon Mar 31 18:09:01 GMT 2025 , Edited by admin on Mon Mar 31 18:09:01 GMT 2025
|
PRIMARY | |||
|
C65698
Created by
admin on Mon Mar 31 18:09:01 GMT 2025 , Edited by admin on Mon Mar 31 18:09:01 GMT 2025
|
PRIMARY | |||
|
100000081001
Created by
admin on Mon Mar 31 18:09:01 GMT 2025 , Edited by admin on Mon Mar 31 18:09:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|